Jul 18, 2022
Dr. Michael Racke is the Medical Director at Quest Advanced Neurology, which is extending the options for neurologic diagnoses by looking for biomarkers in blood tests.
Michael explains, "And now, we're very much involved in developing plasma-based biomarkers to help diagnose Alzheimer's disease. Alzheimer's disease was...
Jul 18, 2022
Dr. Michael Racke is the Medical Director at Quest Advanced Neurology, which is extending the options for neurologic diagnoses by looking for biomarkers in blood tests.
Michael explains, "And now, we're very much involved in developing plasma-based biomarkers to help diagnose Alzheimer's disease. Alzheimer's disease was...
Jul 6, 2022
Dr. Jacob Donoghue is the CEO and Co-Founder of Beacon Biosignals, a computational neurobiomarker discovery and deployment platform taking EEG readings and applying their algorithms to identify novel neurobiomarkers that might be related to a disease that can be modulated by a new therapy.
Jacob drills down, "We anchor...
Jul 6, 2022
Dr. Jacob Donoghue is the CEO and Co-Founder of Beacon Biosignals, a computational neurobiomarker discovery and deployment platform taking EEG readings and applying their algorithms to identify novel neurobiomarkers that might be related to a disease that can be modulated by a new therapy.
Jacob drills down, "We anchor...
Apr 14, 2022
Dave Rosa is the President and CEO of NeuroOne and an entrepreneur with extensive experience in the medical device industry. NeuroOne is developing and commercializing thin-film high-definition electrode technology that can dramatically improve neurosurgery where typically, multiple surgeries are needed for diagnostic...